GT Biopharma Stock Quote GTBP - Stock Price, News, Charts, Message Board, Trades

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

3.52

Bid

3.46

Ask

3.57

Volume

17,080

3.36 Day's Range 3.57

2.9539 52 Week Range 16.11

Market Cap

4.929M

Previous Close

3.565

Open

3.54

Last Trade

3.46

Last Trade Time

Financial Volume

$ 59,678

VWAP

3.494

Average Volume (3m)

1,480,122

Shares Outstanding

1,380,633

Dividend Yield

PE Ratio

-0.65

Earnings Per Share (EPS)

-5.5

Revenue

Net Profit

-7.6M

GT Biopharma Inc is an immuno-oncology company operating in the United States. It is engaged in discovering, developing and commercializing novel therapeutics from its proprietary product platform in a varied range of disease areas. The company mainly develops drugs focused on the treatment of cance... GT Biopharma Inc is an immuno-oncology company operating in the United States. It is engaged in discovering, developing and commercializing novel therapeutics from its proprietary product platform in a varied range of disease areas. The company mainly develops drugs focused on the treatment of cancer. Its key drug candidates are OXS-2175, targeting the treatment of triple-negative breast cancer; OXS-4235, targets the treatment of multiple myeloma and associated osteolytic lesions; and OXS-1550, targets cancer cells expressing the CD19 receptor and CD22 receptor. Its TriKE and TetraKE platforms offer immuno-oncology products that can treat a range of hematologic malignancies, sarcoma, and solid tumors. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.gtbiopharma.com

Headquarters

Wilmington, Delaware, USA

Founded

1970

GT Biopharma Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker GTBP. The last closing price for GT Biopharma was $3.57. Over the last year, GT Biopharma shares have traded in a share price range of $ 2.9539 to $ 16.11.

GT Biopharma currently has 1,380,633 shares outstanding. The market capitalization of GT Biopharma is $4.93 million. GT Biopharma has a price to earnings ratio (PE ratio) of -0.65.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.18	-4.86486486486	3.7	3.89	3.31	68733	3.61440369	CS
4	0.23	6.99088145897	3.29	10.6599	3.02	4493400	7.2460902	CS
12	-1.4	-28.4552845528	4.92	10.6599	2.9539	1480122	7.22991924	CS
26	-2.93	-45.4263565891	6.45	10.6599	2.9539	745835	7.1987931	CS
52	-5.54	-61.1479028698	9.06	16.11	2.9539	540566	7.76051119	CS
156	-490.28	-99.2871607938	493.8	591.993	2.9539	308461	71.4014671	CS
260	-161.48	-97.8666666667	165	591.993	2.9539	339494	109.4008213	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
MLGOMicroAlgo Inc	$ 11.98 (667.95%)	185.75M
VSTEVast Renewable Ltd	$ 4.49 (79.60%)	9.96M
SOBRSOBR Safe Inc	$ 0.4507 (71.04%)	267.96M
MFImF International Ltd	$ 1.315 (41.40%)	2.02M
DHACUDigital Health Acquisition Corporation	$ 23.06 (40.61%)	3.95k
JDZGJIADE Ltd	$ 1.72 (-86.21%)	14.65M
NDRAENDRA Life Sciences Inc	$ 0.086 (-60.37%)	71.57M
ALBTAvalon GloboCare Corporation	$ 0.85 (-30.89%)	5.97M
EQEquillium Inc	$ 1.05 (-28.57%)	10.83M
ATGLAlpha Technology Group Limited	$ 2.86 (-28.32%)	103.33k
SOBRSOBR Safe Inc	$ 0.4507 (71.04%)	267.96M
MLGOMicroAlgo Inc	$ 11.98 (667.95%)	185.75M
SQQQProShares UltraPro Short QQQ	$ 9.86 (-0.70%)	125.46M
FFIEFaraday Future Intelligent Electric Inc	$ 0.557 (-10.85%)	101.47M
CRKNCrown Electrokinetics Corporation	$ 0.1044 (-11.45%)	92.01M